|4Dec 1, 4:00 PM ET

U.S. Stem Cell, Inc. 4

4 · U.S. Stem Cell, Inc. · Filed Dec 1, 2015

Insider Transaction Report

Form 4
Period: 2015-11-02
Comella Kristin C
Chief Science Officer
Transactions
  • Award

    Stock Options (right to buy)

    2015-11-02+175,131192,762 total
    Exercise: $1.71From: 2015-11-02Exp: 2025-11-02Common Stock (175,131 underlying)
  • Award

    Stock Option (right to buy)

    2015-11-02+5,00017,631 total
    Exercise: $6.24Exp: 2025-11-02Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]1,250 vest on 11/02/2016, 1,250 vest on 11/02/2017, 1,250 vest on 11/02/2018, 1,250 vest on 11/02/2019.

Documents

1 file
  • 4
    form4-comella113015.xmlPrimary

    OWNERSHIP DOCUMENT